Profitability and efficiency
- EBITDA: -$854,503; Operating income: -$854,503; Net income: -$809,238; EPS: -0.72; Weighted average shares outstanding: 1,119,798
Cost structure and expense mix
- Research and development: $249,341
- General and administrative: $605,162
- Depreciation and amortization: $14,163
Cash flow and liquidity
- Net cash provided by operating activities: -$738,450
- Capital expenditures: -$2,000
- Purchases of investments: -$200,584; proceeds from investments: $586k
- Net cash used in investing activities: -$201,998
- Net cash provided by financing activities: $104
- Net change in cash: -$940,344
- End of period cash and cash equivalents: $2,371,933; Cash equivalents + short-term investments: $4,671,053
Balance sheet posture
- Total assets: $5,090,991; Total liabilities: $392,107; Total stockholdersโ equity: $4,698,884
- Cash and short-term investments dominate liquidity: cash and cash equivalents $2,371,933; short-term investments $2,299,120
- Net debt vs cash: net debt = -$2,371,933 (i.e., net cash position)
Key per-share metrics and liquidity indicators
- Cash per share: $4.17; P/E (negative earnings): not applicable; FCF per share: -$0.66; CFO per share: -$0.66; Current ratio: 12.47; Quick ratio: 12.47
Revenue context and quarterly cadence
- QQ2 2024 revenue: not disclosed in the filing
- Trailing quarters show limited revenue in prior periods (e.g., Q4 2023 and Q1 2024 reported very small top-line figures in the four-quarter window); overall top-line scale remains minimal as of QQ2 2024